{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:37:10Z","timestamp":1787585830888,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Manipal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>NanoCubes loaded film-forming spray (NanoCuboSpray) is a new formulation that can be explored for nanoscale drug delivery. In the present work, epigallocatechin 3-gallate (EGCG) was encapsulated into NanoCuboSpray (NCS) for oral submucous fibrosis (OSF) treatment. The newly formulated EGCG NCS is then evaluated for <jats:italic>ex vivo<\/jats:italic> permeation, drug retention, <jats:italic>in vivo<\/jats:italic> efficacy, and safety. The developed formulation was homogeneous, viscous, spreadable and mucoadhesive on the buccal mucosa. EGCG NCS had good permeation and buccal mucosal retention in the <jats:italic>ex vivo<\/jats:italic> studies. The NCS with 81.81\u00a0mg\/kg EGCG dose significantly enhanced mouth opening and effectively upregulated collagen and downregulated TGF-\u03b21 in rats with areca nut extract-induced OSF. EGCG NCS demonstrated better improvements in histopathological and antioxidant parameters compared to EGCG hydrogel and betamethasone injection (BTM Inj.). In the safety evaluation, NCS treatment had negligible changes in histopathological features and serum biochemical markers, maintaining results comparable to the normal control group. Therefore, the optimized NCS presents a safer alternative strategy for treating OSF and holds the potential for further evaluation of its clinical efficacy.<\/jats:p>\n          <jats:p>\n            <jats:bold>Graphical Abstract<\/jats:bold>\n          <\/jats:p>","DOI":"10.1208\/s12249-025-03180-x","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T10:02:10Z","timestamp":1751623330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Nanocubospray of Epigallocatechin Gallate for Prevention of Oral Submucous Fibrosis"],"prefix":"10.1208","volume":"26","author":[{"given":"Chetan Hasmukh","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varalakshmi","family":"Velagacherla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Manandhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogendra","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karkala Sreedhara Ranganath","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruthi","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1995-3114","authenticated-orcid":false,"given":"Usha Yogendra","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"3180_CR1","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/hed.23143","volume":"35","author":"P Chaturvedi","year":"2013","unstructured":"Chaturvedi P, Vaishampayan SS, Nair S, Nair D, Agarwal JP, Kane SV, et al. Oral squamous cell carcinoma arising in background of oral submucous fibrosis: a clinicopathologically distinct disease. Head Neck. 2013;35:1404\u20139. https:\/\/doi.org\/10.1002\/hed.23143.","journal-title":"Head Neck"},{"key":"3180_CR2","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.3390\/ijms20122940","volume":"20","author":"YH Shih","year":"2019","unstructured":"Shih YH, Wang TH, Shieh TM, Tseng YH. Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and Therapy. Int J Mol Sci. 2019;20:2940. https:\/\/doi.org\/10.3390\/ijms20122940.","journal-title":"Int J Mol Sci"},{"key":"3180_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102911","volume":"66","author":"CH Mehta","year":"2021","unstructured":"Mehta CH, Narayan R, Acharya S, Nayak UY. Design and development of surface modified epigallocatechin 3-gallate NanoCubogel for localized delivery to oral submucous fibrosis therapy. J Drug Deliv Sci Technol. 2021;66: 102911. https:\/\/doi.org\/10.1016\/j.jddst.2021.102911.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"6","key":"3180_CR4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/jop.12583","volume":"46","author":"G Arakeri","year":"2017","unstructured":"Arakeri G, Rai KK, Boraks G, Patil SG, Aljabab AS, Merkx MAW, Carrozzo M, Brennan PA. Current protocols in the management of oral submucous fibrosis: an update. J Oral Pathol Med. 2017;46(6):418\u201323. https:\/\/doi.org\/10.1111\/jop.12583.","journal-title":"J Oral Pathol Med."},{"issue":"7","key":"3180_CR5","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.joms.2008.12.056","volume":"67","author":"X Jiang","year":"2009","unstructured":"Jiang X, Hu J. Drug treatment of oral submucous fibrosis: a review of the literature. J Oral Maxillofac Surg. 2009;67(7):1510\u20135. https:\/\/doi.org\/10.1016\/j.joms.2008.12.056.","journal-title":"J Oral Maxillofac Surg"},{"key":"3180_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.oooo.2016.04.003","volume":"122","author":"WM Tilakaratne","year":"2016","unstructured":"Tilakaratne WM, Ekanayaka RP, Warnakulasuriya S. Oral submucous fibrosis: a historical perspective and a review on etiology and pathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122:178\u201391. https:\/\/doi.org\/10.1016\/j.oooo.2016.04.003.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2","key":"3180_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/njms.NJMS_32_17","volume":"8","author":"D Passi","year":"2017","unstructured":"Passi D, Bhanot P, Kacker D, Chahal D, Atri M, Panwar Y. Oral submucous fibrosis: newer proposed classification with critical updates in pathogenesis and management strategies. Natl J Maxillofac Surg. 2017;8(2):89\u201394. https:\/\/doi.org\/10.4103\/njms.NJMS_32_17.","journal-title":"Natl J Maxillofac Surg"},{"key":"3180_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/CCID.S80576","volume":"8","author":"U Wollina","year":"2015","unstructured":"Wollina U, Verma SB, Faridi M, Patil K. Oral submucous fibrosis: an update. Clin Cosmet Investig Dermatol. 2015;8:193\u2013204. https:\/\/doi.org\/10.2147\/CCID.S80576.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"3180_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4103\/jomfp.JOMFP_106_14","volume":"21","author":"YV Jani","year":"2017","unstructured":"Jani YV, Chaudhary A, Dudhia B, Bhatia P, Soni N, Patel P. Evaluation of role of trace elements in oral submucous fibrosis patients: a study on Gujarati population. J oral Maxillofac Pathol. 2017;21:455. https:\/\/doi.org\/10.4103\/jomfp.JOMFP_106_14.","journal-title":"J oral Maxillofac Pathol."},{"key":"3180_CR10","unstructured":"Nanocubogel\u00ae Class 5, Trademark no: 5202626, Dated 23\/01\/2023. Trade Marks Registry, Government of India. https:\/\/tmrsearch.ipindia.gov.in\/eregister\/ Accessed 22 June 2024."},{"issue":"5","key":"3180_CR11","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1007\/s10787-023-01212-1","volume":"31","author":"CH Mehta","year":"2023","unstructured":"Mehta CH, Paliwal S, Muttigi MS, Seetharam RN, Prasad ASB, Nayak Y, et al. Polyphenol-based targeted therapy for oral submucous fibrosis. Inflammopharmacology. 2023;31(5):2349\u201368. https:\/\/doi.org\/10.1007\/s10787-023-01212-1.","journal-title":"Inflammopharmacology"},{"key":"3180_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.biopha.2015.01.032","volume":"70","author":"Y Wang","year":"2015","unstructured":"Wang Y, Liu N, Su X, Zhou G, Sun G, Du F, et al. Epigallocatechin-3-gallate attenuates transforming growth factor-\u03b21 induced epithelial-mesenchymal transition via Nrf2 regulation in renal tubular epithelial cells. Biomed Pharmacother. 2015;70:260\u20137. https:\/\/doi.org\/10.1016\/j.biopha.2015.01.032.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"3180_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-024-02787-w","volume":"25","author":"CH Mehta","year":"2024","unstructured":"Mehta CH, Velagacherla V, Manandhar S, Nayak Y, Pai SRK, Acharya S, et al. Development of epigallocatechin 3-gallate-loaded hydrogel nanocomposites for oral submucous fibrosis. AAPS PharmSciTech. 2024;25(4):1\u201315. https:\/\/doi.org\/10.1208\/s12249-024-02787-w.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"3180_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijpharm.2016.08.038","volume":"512","author":"B Liao","year":"2016","unstructured":"Liao B, Ying H, Yu C, Fan Z, Zhang W, Shi J, et al. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice. Int J Pharm. 2016;512(1):22\u201331. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.08.038.","journal-title":"Int J Pharm"},{"issue":"1","key":"3180_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/0975-7406.76478","volume":"3","author":"R Shaikh","year":"2011","unstructured":"Shaikh R, Raj Singh TR, Garland MJ, Woolfson AD, Donnelly RF. Mucoadhesive drug delivery systems. J Pharm Bioallied Sci. 2011;3(1):89\u2013100. https:\/\/doi.org\/10.4103\/0975-7406.76478.","journal-title":"J Pharm Bioallied Sci"},{"key":"3180_CR16","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.2147\/DDDT.S256666","volume":"14","author":"AK Umar","year":"2020","unstructured":"Umar AK, Butarbutar M, Sriwidodo S, Wathoni N. Film-forming sprays for topical drug delivery. Drug Des Devel Ther. 2020;14:2909\u201325. https:\/\/doi.org\/10.2147\/DDDT.S256666.","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"3180_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3109\/17435390.2011.580863","volume":"6","author":"E Roblegg","year":"2012","unstructured":"Roblegg E, Fr\u00f6hlich E, Meindl C, Teubl B, Zaversky M, Zimmer A. Evaluation of a physiological in vitro system to study the transport of nanoparticles through the buccal mucosa. Nanotoxicology. 2012;6(4):399\u2013413. https:\/\/doi.org\/10.3109\/17435390.2011.580863.","journal-title":"Nanotoxicology"},{"key":"3180_CR18","doi-asserted-by":"publisher","first-page":"12037","DOI":"10.33263\/BRIAC114.1203712054","volume":"11","author":"AK Chettupalli","year":"2021","unstructured":"Chettupalli AK, Ananthula M, Amarachinta PR, Bakshi V, Yata VK. Design, formulation, in-vitro and ex-vivo evaluation of atazanavir loaded cubosomal gel. Biointerface Res Appl Chem. 2021;11:12037\u201354. https:\/\/doi.org\/10.33263\/BRIAC114.1203712054.","journal-title":"Biointerface Res Appl Chem."},{"issue":"7","key":"3180_CR19","first-page":"492","volume":"8","author":"B Sulekha","year":"2016","unstructured":"Sulekha B, Avin G. Topical spray of silver sulfadiazine for wound healing. J Chem Pharm Res. 2016;8(7):492\u20138.","journal-title":"J Chem Pharm Res"},{"issue":"6","key":"3180_CR20","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ajps.2017.07.004","volume":"12","author":"K Kathe","year":"2017","unstructured":"Kathe K, Kathpalia H. Film forming systems for topical and transdermal drug delivery. Asian J Pharm Sci. 2017;12(6):487\u201397. https:\/\/doi.org\/10.1016\/j.ajps.2017.07.004.","journal-title":"Asian J Pharm Sci"},{"issue":"11","key":"3180_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12247-022-09703-4","volume":"18","author":"ER Rani","year":"2023","unstructured":"Rani ER, Radha GV. Investigation of in vivo bioavailability enhancement of iloperidone-loaded solid self-nanoemulsifying drug delivery systems: formulation and optimization using box-behnken design and desirability function. J Pharm Innov. 2023;18(11):1\u201317. https:\/\/doi.org\/10.1007\/s12247-022-09703-4.","journal-title":"J Pharm Innov"},{"issue":"1\u20132","key":"3180_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ijpharm.2015.04.011","volume":"488","author":"MH Mahdi","year":"2015","unstructured":"Mahdi MH, Conway BR, Smith AM. Development of mucoadhesive sprayable gellan gum fluid gels. Int J Pharm. 2015;488(1\u20132):12\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.04.011.","journal-title":"Int J Pharm"},{"issue":"6","key":"3180_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.22159\/ijap.2021v13i6.42589","volume":"13","author":"MF Mustaffa","year":"2021","unstructured":"Mustaffa MF, Ramasamy K, Jaafar N, Hasan MH, Ramli NA, Suratman S, et al. In-situ film-forming solution for topical application of terbinafine HCl: biopharmaceutical evaluation and in vivo antifungal performance using animal model. Int J Appl Pharm. 2021;13(6):98\u2013105. https:\/\/doi.org\/10.22159\/ijap.2021v13i6.42589.","journal-title":"Int J Appl Pharm."},{"issue":"1","key":"3180_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bfopcu.2017.01.001","volume":"55","author":"NM Mori","year":"2017","unstructured":"Mori NM, Patel P, Sheth NR, Rathod LV, Ashara KC. Fabrication and characterization of film-forming voriconazole transdermal spray for the treatment of fungal infection. Bull Fac Pharmacy, Cairo Univ. 2017;55(1):41\u201351. https:\/\/doi.org\/10.1016\/j.bfopcu.2017.01.001.","journal-title":"Bull Fac Pharmacy, Cairo Univ"},{"issue":"8","key":"3180_CR25","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1080\/21691401.2016.1252384","volume":"45","author":"MP More","year":"2017","unstructured":"More MP, Patil MD, Pandey AP, Patil PO, Deshmukh PK. Fabrication and characterization of graphene-based hybrid nanocomposite: assessment of antibacterial potential and biomedical application. Artif Cells Nanomedicine Biotechnol. 2017;45(8):1496\u2013508. https:\/\/doi.org\/10.1080\/21691401.2016.1252384.","journal-title":"Artif Cells Nanomedicine Biotechnol"},{"key":"3180_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2019.111469","volume":"293","author":"CH Mehta","year":"2019","unstructured":"Mehta CH, Narayan R, Aithal G, Pandiyan S, Bhat P, Dengale S, et al. Molecular simulation driven experiment for formulation of fixed dose combination of Darunavir and Ritonavir as anti-HIV nanosuspension. J Mol Liq. 2019;293: 111469. https:\/\/doi.org\/10.1016\/j.molliq.2019.111469.","journal-title":"J Mol Liq"},{"issue":"10","key":"3180_CR27","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.3109\/03639045.2014.1002408","volume":"41","author":"M Paradkar","year":"2015","unstructured":"Paradkar M, Thakkar V, Soni T, Gandhi T, Gohel M. Formulation and evaluation of clotrimazole transdermal spray. Drug Dev Ind Pharm. 2015;41(10):1718\u201325. https:\/\/doi.org\/10.3109\/03639045.2014.1002408.","journal-title":"Drug Dev Ind Pharm"},{"issue":"7","key":"3180_CR28","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1111\/odi.13409","volume":"26","author":"MH Chiang","year":"2020","unstructured":"Chiang MH, Lee KT, Chen CH, Chen KK, Wang YH. Photobiomodulation therapy inhibits oral submucous fibrosis in mice. Oral Dis. 2020;26(7):1474\u201382. https:\/\/doi.org\/10.1111\/odi.13409.","journal-title":"Oral Dis"},{"issue":"1","key":"3180_CR29","first-page":"53","volume":"10","author":"HH Chow","year":"2001","unstructured":"Chow HH, Cai Y, Alberts DS, Hakim I, Dorr R, Shahi F, et al. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomark Prev. 2001;10(1):53\u20138.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"3180_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1208\/s12249-010-9570-1","volume":"12","author":"MA Mughal","year":"2011","unstructured":"Mughal MA, Iqbal Z, Neau SH. Guar gum, xanthan gum, and HPMC can define release mechanisms and sustain release of propranolol hydrochloride. AAPS PharmSciTech. 2011;12(1):77\u201387. https:\/\/doi.org\/10.1208\/s12249-010-9570-1.","journal-title":"AAPS PharmSciTech"},{"key":"3180_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/697434","volume":"2014","author":"W Lu","year":"2014","unstructured":"Lu W, Luo H, Zhu Z, Wu Y, Luo J, Wang H. Preparation and the biopharmaceutical evaluation for the metered dose transdermal spray of dexketoprofen. J Drug Deliv. 2014;2014: 697434. https:\/\/doi.org\/10.1155\/2014\/697434.","journal-title":"J Drug Deliv"},{"issue":"1","key":"3180_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jsps.2022.11.014","volume":"31","author":"EO Bakhrushina","year":"2023","unstructured":"Bakhrushina EO, Shumkova MM, Sergienko FS, Novozhilova EV, Demina NB. Spray film-forming systems as promising topical in situ systems: a review. Saudi Pharm J. 2023;31(1):154\u201369. https:\/\/doi.org\/10.1016\/j.jsps.2022.11.014.","journal-title":"Saudi Pharm J"},{"issue":"6","key":"3180_CR33","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.apsb.2013.10.003","volume":"3","author":"W Lu","year":"2013","unstructured":"Lu W, Luo H, Wu Y, Zhu Z, Wang H. Preparation and characterization of a metered dose transdermal spray for testosterone. Acta Pharm Sin B. 2013;3(6):392\u20139. https:\/\/doi.org\/10.1016\/j.apsb.2013.10.003.","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"3180_CR34","doi-asserted-by":"publisher","first-page":"320","DOI":"10.5530\/ijpi.2020.3.57","volume":"10","author":"R Kale","year":"2020","unstructured":"Kale R, Doifode D, Shete P. Film forming, antimicrobial and growth promoting wound healing spray formulation. Int J Pharm Investig. 2020;10(3):320\u20135. https:\/\/doi.org\/10.5530\/ijpi.2020.3.57.","journal-title":"Int J Pharm Investig"},{"issue":"1","key":"3180_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/gels11010064","volume":"11","author":"J Angsusing","year":"2025","unstructured":"Angsusing J, Samee W, Tadtong S, Mangmool S, Okonogi S, Toolmal N, et al. Development, optimization, and stability study of a yataprasen film-forming spray for musculoskeletal pain management. Gels. 2025;11(1):64. https:\/\/doi.org\/10.3390\/gels11010064.","journal-title":"Gels"},{"issue":"2","key":"3180_CR36","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jobcr.2020.03.015","volume":"10","author":"A Rai","year":"2020","unstructured":"Rai A, Ahmad T, Parveen S, Parveen S, Faizan MI, Ali S. Expression of transforming growth factor beta in oral submucous fibrosis. J Oral Biol Craniofacial Res. 2020;10(2):166\u201370. https:\/\/doi.org\/10.1016\/j.jobcr.2020.03.015.","journal-title":"J Oral Biol Craniofacial Res"},{"issue":"01\u201303","key":"3180_CR37","first-page":"15","volume":"44","author":"JDR Perera","year":"2014","unstructured":"Perera JDR, Sivakanesan R, Jayasinghe RD, Bandara BMR, Tilakaratne WM. Role of antioxidants in disease progression and malignant transformation of oral submucous fibrosis (A Preliminary Study). Sri Lanka Dent J. 2014;44(01\u201303):15\u201323.","journal-title":"Sri Lanka Dent J"},{"issue":"11","key":"3180_CR38","first-page":"1328","volume":"9","author":"A Yadav","year":"2016","unstructured":"Yadav A, Kumari R, Yadav A, Mishra JP, Srivastva S, Prabha S. Antioxidants and its functions in human body-a review. Res Environ Life Sci. 2016;9(11):1328\u201331.","journal-title":"Res Environ Life Sci"},{"issue":"Suppl 1","key":"3180_CR39","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.4103\/0976-237X.166823","volume":"6","author":"GK Shakunthala","year":"2022","unstructured":"Shakunthala GK, Annigeri RG, Arunkumar S. Role of oxidative stress in the pathogenesis of oral submucous fibrosis: a preliminary prospective study. Contemp Clin Dent. 2022;6(Suppl 1):S172-174. https:\/\/doi.org\/10.4103\/0976-237X.166823.","journal-title":"Contemp Clin Dent"},{"issue":"1","key":"3180_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/0975-5950.85864","volume":"2","author":"IB Kar","year":"2011","unstructured":"Kar IB, Sethi AK. A rare ocular complication following treatment of oral submucous fibrosis with steroids. Natl J Maxillofac Surg. 2011;2(1):93\u20135. https:\/\/doi.org\/10.4103\/0975-5950.85864.","journal-title":"Natl J Maxillofac Surg"},{"key":"3180_CR41","doi-asserted-by":"publisher","unstructured":"Chen H-M, Shih C-C, Yen KL, Wang S-M, Kuo Y-S, Kuo MY-P, et al. Facial candida albicans cellulitis occurring in a patient with oral submucous fibrosis and unknown diabetes mellitus after local corticosteroid injection treatment. J Oral Pathol Med. 2004;33(4):243-5. https:\/\/doi.org\/10.1111\/j.0904-2512.2004.00058.x.","DOI":"10.1111\/j.0904-2512.2004.00058.x"},{"issue":"2","key":"3180_CR42","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.13005\/bpj\/1198","volume":"10","author":"G Srikanth","year":"2017","unstructured":"Srikanth G, Komal S, Jyotsna R, Kalyana CP. Unusual complication of intralesional corticosteroid in oral submucous fibrosis patient. Biomed Pharmacol J. 2017;10(2):1009\u201313. https:\/\/doi.org\/10.13005\/bpj\/1198.","journal-title":"Biomed Pharmacol J."},{"issue":"10","key":"3180_CR43","doi-asserted-by":"publisher","first-page":"ZC58","DOI":"10.7860\/jcdr\/2016\/20294.8651","volume":"10","author":"D Pandya","year":"2016","unstructured":"Pandya D, Nagrajappa AK, Ravi KS. Assessment and correlation of urea and creatinine levels in saliva and serum of patients with chronic kidney disease, diabetes and hypertension- a research study. J Clin diagnostic Res. 2016;10(10):ZC58-62. https:\/\/doi.org\/10.7860\/jcdr\/2016\/20294.8651.","journal-title":"J Clin diagnostic Res."},{"issue":"6","key":"3180_CR44","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/(SICI)1097-0282(199911)50:6<641::AID-BIP8>3.0.CO;2-D","volume":"50","author":"R Tuinier","year":"1999","unstructured":"Tuinier R, Zoon P, Stuart MA, Fleer GJ, de Kruif CG. Concentration and shear-rate dependence of the viscosity of an exocellular polysaccharide. Biopolymers. 1999;50(6):641\u20136. https:\/\/doi.org\/10.1002\/(SICI)1097-0282(199911)50:6%3c641::AID-BIP8%3e3.0.CO;2-D.","journal-title":"Biopolymers"},{"key":"3180_CR45","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1208\/s12249-009-9256-8","volume":"10","author":"MC Gohel","year":"2009","unstructured":"Gohel MC, Nagori SA. Fabrication of modified transport fluconazole transdermal spray containing ethyl cellulose and eudragit\u00ae RS100 as film formers. AAPS PharmSciTech. 2009;10:691. https:\/\/doi.org\/10.1208\/s12249-009-9256-8.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"3180_CR46","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s13197-011-0522-x","volume":"51","author":"D Mudgil","year":"2014","unstructured":"Mudgil D, Barak S, Khatkar BS. Guar gum: processing, properties and food applications-a review. J Food Sci Technol. 2014;51(3):409\u201318. https:\/\/doi.org\/10.1007\/s13197-011-0522-x.","journal-title":"J Food Sci Technol"},{"issue":"6","key":"3180_CR47","doi-asserted-by":"publisher","first-page":"22","DOI":"10.7324\/JAPS.2018.8604","volume":"8","author":"MHS Dawoud","year":"2018","unstructured":"Dawoud MHS, Yassin GE, Ghorab DM, Morsi NM. Response surface optimization and in-vitro evaluation of sustained release topical insulin liposomal spray for wound healing. J Appl Pharm Sci. 2018;8(6):22\u20139. https:\/\/doi.org\/10.7324\/JAPS.2018.8604.","journal-title":"J Appl Pharm Sci"},{"issue":"6","key":"3180_CR48","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4103\/0250-474x.174993","volume":"77","author":"S Agarwal","year":"2015","unstructured":"Agarwal S, Murthy RSR. Effect of different polymer concentration on drug release rate and physicochemical properties of mucoadhesive gastroretentive tablets. Indian J Pharm Sci. 2015;77(6):705\u201314. https:\/\/doi.org\/10.4103\/0250-474x.174993.","journal-title":"Indian J Pharm Sci"},{"key":"3180_CR49","doi-asserted-by":"publisher","first-page":"138","DOI":"10.12688\/f1000research.142860.1","volume":"13","author":"A Shetty","year":"2024","unstructured":"Shetty A, Dubey A, Chrystle J, M M, John A, et al. Fabrication and in vitro characterization of curcumin film-forming topical spray: an integrated approach for enhanced patient comfort and efficacy. F1000Research. 2024;13:138. https:\/\/doi.org\/10.12688\/f1000research.142860.1.","journal-title":"F1000Research."},{"key":"3180_CR50","doi-asserted-by":"publisher","unstructured":"Chethan Aradhya BV, Britto F, Savitha Lakshmi Kaikure HG, Paul T, UpamaSishan, Abdulrashid B et al. Antioxidant-oxidants to assess the oxidative stress in oral submucous fibrosis- an original study. Int J Curr Adv Res. 2018;7(8F):14973\u20135. https:\/\/doi.org\/10.24327\/ijcar.2018","DOI":"10.24327\/ijcar.2018"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03180-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03180-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03180-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T03:50:52Z","timestamp":1753933852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03180-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["3180"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03180-x","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"4 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work does not involve any human trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors have no relevant financial or non-financial interests to disclose. Further, authors declare that there is no funding involved in the manuscript writing, editing, approval, or decision to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"184"}}